SINOVAC BIOTECH
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), and mumps, as well as animal rabies vaccine for canines. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, Panflu.1, and has manufacture... d it for the Chinese Central Government, pursuant to the government-stockpiling program. The company is also the only supplier of the H5N1 pandemic influenza vaccine to the government-stockpiling program. Sinovac is developing a number of new pipeline vaccines including vaccines for enterovirus 71 (against hand, foot, and mouth disease), of which the EV71 vaccine is currently in Phase III clinical trials, pneumococcal conjugate, pneumococcal polysaccharides, and rubella. Sinovac sells its vaccines mainly in China and exports selected vaccines to Mongolia, Nepal, and the Philippines.
SINOVAC BIOTECH
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2001-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.sinovacbio.com
Total Employee:
501+
Status:
Active
Contact:
+86 10 8289 0088
Email Addresses:
[email protected]
Total Funding:
96.33 M USD
Technology used in webpage:
Euro Pound Sterling Japanese Yen HiChina DNS Choopa
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Skye Bioscience
Skye Bioscience is a biopharmaceutical company focused on the discovery, development, and the commercialization.
Protalix BioTherapeutics
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.
Zhenge Biotech
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Current Employees Featured
Founder
Stock Details
Investors List
Vivo Capital
Vivo Capital investment in Post-IPO Equity - Sinovac Biotech
Advantech Capital
Advantech Capital investment in Post-IPO Equity - Sinovac Biotech
Spark Investment Management
Spark Investment Management investment in Post-IPO Equity - Sinovac Biotech
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-15 | Sepax Technologies | Sinovac Biotech investment in Series D - Sepax Technologies | 500 M CNY |
